Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3738021019 | Agalsidase beta only product in parenteral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3738022014 | Product containing only agalsidase beta in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Agalsidase beta only product in parenteral dose form | Has active ingredient | Agalsidase beta (substance) | true | Inferred relationship | Some | 1 | |
| Agalsidase beta only product in parenteral dose form | Count of base of active ingredient | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | ||
| Agalsidase beta only product in parenteral dose form | Is a | Product containing only agalsidase beta (medicinal product) | true | Inferred relationship | Some | ||
| Agalsidase beta only product in parenteral dose form | Is a | Agalsidase beta-containing product in parenteral dose form | true | Inferred relationship | Some | ||
| Agalsidase beta only product in parenteral dose form | Has manufactured dose form | Parenteral dose form (dose form) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Agalsidase beta 5 mg powder for solution for injection vial | Is a | True | Agalsidase beta only product in parenteral dose form | Inferred relationship | Some | |
| Agalsidase beta 35 mg powder for solution for injection vial | Is a | True | Agalsidase beta only product in parenteral dose form | Inferred relationship | Some |
Reference Sets
FHIR